Ion Channels and Osteoarthritic Pain: Potential for Novel Analgesics

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

1. 1.
   Conaghan P. Osteoarthritis: national clinical guideline for care and management in adults. Publisher: Royal College of Physicians. (2008). http://www.nice.org.uk/nicemedia/pdf/cg59niceguideline.pdf.
2. 2.
   Kidd BL, Urban LA. Mechanisms of inflammatory pain. Br J Anaesth. 2001;87(1):3–11.PubMedGoogle Scholar
3. 3.
   Dray A, Read SJ. Arthritis and pain. Future targets to control osteoarthritis pain. Arthritis Res Ther. 2007;9(3):212.PubMedGoogle Scholar
4. 4.
   Zhang RX, Ren K, Dubner R. Osteoarthritis pain mechanisms: basic studies in animal models. Osteoarthr Cartil. 2013;21(9):1308–15.PubMedGoogle Scholar
5. 5.
   Marshall KW, Theriault E, Homonko DA. Distribution of substance P and calcitonin gene related peptide immunoreactivity in the normal feline knee. J Rheumatol. 1994;21(5):883–9.PubMedGoogle Scholar
6. 6.
   Schaible H-G et al. Joint pain. Exp Brain Res. 2009;196(1):153–62.PubMedGoogle Scholar
7. 7.
   Oliva F, Tarantino U, Maffulli N. Immunohistochemical localization of calcitonin gene-related peptide and substance P in the rat knee cartilage at birth. Physiol Res. 2005;54(5):549–56.PubMedGoogle Scholar
8. 8.
   Suri S et al. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann Rheum Dis. 2007;66(11):1423–8.PubMedGoogle Scholar
9. 9.
   Mapp PI, Walsh DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol. 2012;8(7):390–8.PubMedGoogle Scholar
10. 10.
    • Hunter DJ et al. Structural correlates of pain in joints with osteoarthritis. Osteoarthr Cartil. 2013;21(9):1170–8. This paper highlights that there is a correlation between OA pain and the degree of joint damage.PubMedGoogle Scholar
11. 11.
    Cotofana S et al. Relationship between knee pain and the presence, location, size and phenotype of femorotibial denuded areas of subchondral bone as visualized by MRI. Osteoarthr Cartil. 2013;21(9):1214–22.PubMedGoogle Scholar
12. 12.
    • Konttinen YT et al. Osteoarthritis as an autoinflammatory disease caused by chondrocyte-mediated inflammatory responses. Arthritis Rheum. 2012;64(3):613–6. This paper explores the links between biomechanical and inflammatory effects of OA.PubMedGoogle Scholar
13. 13.
    Mobasheri A. Role of chondrocyte death and hypocellularity in ageing human articular cartilage and the pathogenesis of osteoarthritis. Med Hypotheses. 2002;58(3):193–7.PubMedGoogle Scholar
14. 14.
    Verbruggen G. Chondroprotective drugs in degenerative joint diseases. Rheumatology (Oxford). 2006;45(2):129–38.Google Scholar
15. 15.
    Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol. 2007;213(3):626–34.PubMedGoogle Scholar
16. 16.
    Hunter DJ, Felson DT. Osteoarthritis. Br Med J. 2006;332(7542):639–42.Google Scholar
17. 17.
    Cawston TE, Wilson AJ. Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Pract Res Clin Rheumatol. 2006;20(5):983–1002.PubMedGoogle Scholar
18. 18.
    Reynard LN and Loughlin J. Insights from human genetic studies into the pathways involved in osteoarthritis. Nat Rev Rheumatol. 2013. doi: 10.1038/nrrheum.2013.121
19. 19.
    Chen R, Brady E, McIntyre TM. Human TMEM30a promotes uptake of antitumor and bioactive choline phospholipids into mammalian cells. J Immunol. 2011;186(5):3215–25.PubMedGoogle Scholar
20. 20.
    •• Brines ML, Ling Z, Broadus AE. Parathyroid hormone-related protein protects against kainic acid excitotoxicity in rat cerebellar granule cells by regulating L-type channel calcium flux. Neurosci Lett. 1999;274(1):13–6. This paper showed that only five genes were associated with OA pain.PubMedGoogle Scholar
21. 21.
    Bond SR et al. Pannexin 3 is a novel target for Runx2, expressed by osteoblasts and mature growth plate chondrocytes. J Bone Miner Res. 2011;26(12):2911–22.PubMedGoogle Scholar
22. 22.
    • Uchiyama Y et al. SMAD3 functions as a transcriptional repressor of acid-sensing ion channel 3 (ASIC3) in nucleus pulposus cells of the intervertebral disc. J Bone Miner Res. 2008;23(10):1619–28. This paper summarises all the ion channels changed in OA as identified by bioinformatics studies.PubMedGoogle Scholar
23. 23.
    Thakur M, Dawes JM, McMahon SB. Genomics of pain in osteoarthritis. Osteoarthr Cartil. 2013;21(9):1374–82.PubMedGoogle Scholar
24. 24.
    Chen CT et al. Chondrocyte necrosis and apoptosis in impact damaged articular cartilage. J Orthop Res. 2001;19(4):703–11.PubMedGoogle Scholar
25. 25.
    Lewis R, Feetham C, Barrett-Jolley R. Cell volume control in chondrocytes. Cell Physiol Biochem. 2011;28(6):1111–22.PubMedGoogle Scholar
26. 26.
    Kumagai K et al. 17β-Estradiol inhibits the doxorubicin-induced apoptosis via block of volume-sensitive Cl− current in rabbit articular chondrocytes. Br J Pharmacol. 2012;166(2):702–20.PubMedGoogle Scholar
27. 27.
    Mobasheri A et al. Characterization of a stretch-activated potassium channel in chondrocytes. J Cell Physiol. 2010;223(2):511–8.PubMedGoogle Scholar
28. 28.
    Lewis R et al. Chondrocyte channel transcriptomics: Do microarray data fit with expression and functional data? Channels. 2013;7(6).Google Scholar
29. 29.
    Mobasheri A et al. Evidence for functional ATP-sensitive (K(ATP)) potassium channels in human and equine articular chondrocytes. Osteoarthr Cartil. 2007;15(1):1–8.PubMedGoogle Scholar
30. 30.
    Rufino AT et al. Expression and function of K(ATP) channels in normal and osteoarthritic human chondrocytes: possible role in glucose sensing. J Cell Biochem. 2013;114(8):1879–89.PubMedGoogle Scholar
31. 31.
    Mobasheri A et al. Potassium channels in articular chondrocytes. Channels. 2012;6(6):416–25.PubMedGoogle Scholar
32. 32.
    Barrett-Jolley R. et al. The emerging chondrocyte channelome. Front Membr Physiol Biophys. 2010;1(135). doi: 10.3389/fphys.2010.00135
33. 33.
    Lewis R et al. Benzamil sensitive ion channels contribute to volume regulation in canine chondrocytes. Br J Pharmacol. 2013;168(7):1584–96.PubMedGoogle Scholar
34. 34.
    Docherty RJ et al. TRPA1 insensitivity of human sural nerve axons after exposure to lidocaine. Pain. 2013;154(9):1569–77.PubMedGoogle Scholar
35. 35.
    Lofstrom B. Aspects of the pharmacology of local anaesthetic agents. Br J Anaesth. 1970;42(3):194–206.PubMedGoogle Scholar
36. 36.
    Creamer P, Hunt M, Dieppe P. Pain mechanisms in osteoarthritis of the knee: effect of intraarticular anesthetic. J Rheumatol. 1996;23(6):1031–6.PubMedGoogle Scholar
37. 37.
    Crawford RW et al. Diagnostic value of intra-articular anaesthetic in primary osteoarthritis of the hip. J Bone Joint Surg Br. 1998;80(2):279–81.PubMedGoogle Scholar
38. 38.
    Fernandes L, Goodwill CJ, Wright MG. Local anaesthetic nerve block in the treatment of intractable pain from osteoarthritis of the hip. Rheumatol Rehabil. 1978;17(4):249–53.PubMedGoogle Scholar
39. 39.
    Hennig GS et al. Evaluation of chondrocyte death in canine osteochondral explants exposed to a 0.5% solution of bupivacaine. Am J Vet Res. 2010;71(8):875–83.PubMedGoogle Scholar
40. 40.
    Malfait AM, Little CB, McDougall JJ. A commentary on modelling osteoarthritis pain in small animals. Osteoarthr Cartil. 2013;21(9):1316–26.PubMedGoogle Scholar
41. 41.
    Just S, Leipold-Buttner C, Heppelmann B. Histological demonstration of voltage dependent calcium channels on calcitonin gene-related peptide-immunoreactive nerve fibres in the mouse knee joint. Neurosci Lett. 2001;312(3):133–6.PubMedGoogle Scholar
42. 42.
    Ichikawa H et al. VR1-, VRL-1- and P2X3 receptor-immunoreactive innervation of the rat temporomandibular joint. Brain Res. 2004;1008(1):131–6.PubMedGoogle Scholar
43. 43.
    Baker CL, McDougall JJ. The cannabinomimetic arachidonyl-2-chloroethylamide (ACEA) acts on capsaicin-sensitive TRPV1 receptors but not cannabinoid receptors in rat joints. Br J Pharmacol. 2004;142(8):1361–7.PubMedGoogle Scholar
44. 44.
    Fernihough J et al. Regulation of calcitonin gene-related peptide and TRPV1 in a rat model of osteoarthritis. Neurosci Lett. 2005;388(2):75–80.PubMedGoogle Scholar
45. 45.
    Lewis R et al. The role of the membrane potential in chondrocyte volume regulation. J Cell Physiol. 2011;226(11):2979–86.PubMedGoogle Scholar
46. 46.
    Heppelmann B, McDougall JJ. Inhibitory effect of amiloride and gadolinium on fine afferent nerves in the rat knee: evidence of mechanogated ion channels in joints. Exp Brain Res. 2005;167(1):114–8.PubMedGoogle Scholar
47. 47.
    Denadai-Souza A et al. Role of transient receptor potential vanilloid 4 in rat joint inflammation. Arthritis Rheum. 2012;64(6):1848–58.PubMedGoogle Scholar
48. 48.
    Guilak F, Leddy HA, and Liedtke W. Transient receptor potential vanilloid 4. Ann N Y Acad Sci. 2010;1192:404–9.Google Scholar
49. 49.
    Pena Ede L et al. Elastoviscous substances with analgesic effects on joint pain reduce stretch-activated ion channel activity in vitro. Pain. 2002;99(3):501–8.PubMedGoogle Scholar
50. 50.
    Schuelert N, McDougall JJ. Involvement of Nav 1.8 sodium ion channels in the transduction of mechanical pain in a rodent model of osteoarthritis. Arthritis Res Ther. 2012;14(1):R5.PubMedGoogle Scholar
51. 51.
    Efe T et al. Penetration of topical diclofenac sodium 4 % spray gel into the synovial tissue and synovial fluid of the knee: a randomised clinical trial. Knee Surg Sports Traumatol Arthrosc. 2013;1–6.Google Scholar
52. 52.
    Kang KS, Bulstrode C. Accelerated progression of osteoarthritis after hip block: a retrospective matched control study. Ann R Coll Surg Engl. 1991;73(2):124–5.PubMedGoogle Scholar
53. 53.
    Pelletier JP et al. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase. J Rheumatol. 2001;28(11):2509–19.PubMedGoogle Scholar
54. 54.
    Pelletier J-P, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: Potential implication for the selection of new therapeutic targets. Arthritis Rheum. 2001;44(6):1237–47.PubMedGoogle Scholar
55. 55.
    Grunke M, Schulze-Koops H. Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade. Ann Rheum Dis. 2006;65(4):555–6.PubMedGoogle Scholar
56. 56.
    Czeschik JC et al. TNF-alpha differentially modulates ion channels of nociceptive neurons. Neurosci Lett. 2008;434(3):293–8.PubMedGoogle Scholar
57. 57.
    Faber CG et al. Gain-of-function Nav1.8 mutations in painful neuropathy. Proc Natl Acad Sci U S A. 2012;109(47):19444–9.PubMedGoogle Scholar
58. 58.
    Matsushita Y et al. HDAC inhibitors restore C-fiber sensitivity in experimental neuropathic pain model. Br J Pharmacol. 2013;170:991–998Google Scholar
59. 59.
    •• Natura G et al. Neuronal prostaglandin E2 receptor subtype EP3 mediates antinociception during inflammation. Proc Natl Acad Sci. 2013;110:13648–53. This paper shows for the first time that the GIRK channel is central to peripheral neuronal cell processing, and importantly, that this channel is absent in mice but not in humans or rats. Google Scholar
60. 60.
    Jarvis MF et al. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci U S A. 2007;104(20):8520–5.PubMedGoogle Scholar
61. 61.
    Xie W et al. Knockdown of sodium channel NaV1.6 blocks mechanical pain and abnormal bursting activity of afferent neurons in inflamed sensory ganglia. Pain. 2013;154(8):1170–80.PubMedGoogle Scholar
62. 62.
    Strickland IT et al. Changes in the expression of NaV1.7, NaV1.8 and NaV1.9 in a distinct population of dorsal root ganglia innervating the rat knee joint in a model of chronic inflammatory joint pain. Eur J Pain. 2008;12(5):564–72.PubMedGoogle Scholar
63. 63.
    Kolker SJ et al. Acid-sensing ion channel 3 expressed in type B synoviocytes and chondrocytes modulates hyaluronan expression and release. Ann Rheum Dis. 2010;69(5):903–9.PubMedGoogle Scholar
64. 64.
    Yuan F-L et al. Inhibition of acid-sensing ion channels in articular chondrocytes by amiloride attenuates articular cartilage destruction in rats with adjuvant arthritis. Inflamm Res. 2010;59(11):939–47.PubMedGoogle Scholar
65. 65.
    Izumi M et al. Local ASIC3 modulates pain and disease progression in a rat model of osteoarthritis. J Biomed Sci. 2012;19:77.PubMedGoogle Scholar
66. 66.
    Ikeuchi M et al. Role of ASIC3 in the primary and secondary hyperalgesia produced by joint inflammation in mice. Pain. 2008;137(3):662–9.PubMedGoogle Scholar
67. 67.
    Dube GR et al. Electrophysiological and in vivo characterization of A-317567, a novel blocker of acid sensing ion channels. Pain. 2005;117(1–2):88–96.PubMedGoogle Scholar
68. 68.
    Zhang P, Canessa CM. Single Channel Properties of Rat Acid–sensitive Ion Channel-1α, -2a, and -3 Expressed in Xenopus Oocytes. J Gen Physiol. 2002;120(4):553–66.PubMedGoogle Scholar
69. 69.
    Wickenden AD. K+ channels as therapeutic drug targets. Pharmacol Ther. 2002;94(1–2):157–82.PubMedGoogle Scholar
70. 70.
    Zöllner C, Stein C. Opioids. In: Stein C, editor. Analgesia. Berlin Heidelberg: Springer Berlin; 2007. p. 31–63.Google Scholar
71. 71.
    Nockemann D et al. The K + channel GIRK2 is both necessary and sufficient for peripheral opioid-mediated analgesia. EMBO Mol Med. 2013;5(8):1263–77.PubMedGoogle Scholar
72. 72.
    Dray A, Perkins M. Bradykinin and inflammatory pain. Trends Neurosci. 1993;16(3):99–104.PubMedGoogle Scholar
73. 73.
    Liu B et al. The acute nociceptive signals induced by bradykinin in rat sensory neurons are mediated by inhibition of M-type K+ channels and activation of Ca2+ -activated Cl- channels. J Clin Investig. 2010;120(4):1240–52.PubMedGoogle Scholar
74. 74.
    Green PG, Levine JD. δ- and κ-opioid agonists inhibit plasma extravasation induced by bradykinin in the knee joint of the rat. Neuroscience. 1992;49(1):129–33.PubMedGoogle Scholar
75. 75.
    Meini S, Maggi CA. Knee osteoarthritis: a role for bradykinin? Inflamm Res. 2008;57(8):351–61.PubMedGoogle Scholar
76. 76.
    Meini S et al. Bradykinin and B(2) receptor antagonism in rat and human articular chondrocytes. Br J Pharmacol. 2011;162(3):611–22.PubMedGoogle Scholar
77. 77.
    von Banchet GS et al. Monoarticular antigen-induced arthritis leads to pronounced bilateral upregulation of the expression of neurokinin 1 and bradykinin 2 receptors in dorsal root ganglion neurons of rats. Arthritis Res. 2000;2(5):424–7.Google Scholar
78. 78.
    Gomis A et al. Blockade of nociceptive sensory afferent activity of the rat knee joint by the bradykinin B2 receptor antagonist fasitibant. Osteoarthr Cartil. 2013;21(9):1346–54.PubMedGoogle Scholar
79. 79.
    Neugebauer V, Schaible HG, Schmidt RF. Sensitization of articular afferents to mechanical stimuli by bradykinin. Pflugers Arch. 1989;415(3):330–5.PubMedGoogle Scholar
80. 80.
    Cialdai C et al. Effect of Intra-articular 4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfo namido]-tetrahydro-2H-4-pyranylcarbonyl} piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132), a kinin B2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats. J Pharmacol Exp Ther. 2009;331(3):1025–32.PubMedGoogle Scholar
81. 81.
    Alexander SP, Mathie A, Peters JA. Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol. 2011;164:1–2.Google Scholar
82. 82.
    Hatch RJ, Jennings EA, Ivanusic JJ. Peripheral hyperpolarization-activated cyclic nucleotide-gated channels contribute to inflammation-induced hypersensitivity of the rat temporomandibular joint. Eur J Pain. 2013;17(7):972–82.PubMedGoogle Scholar
83. 83.
    Voets T et al. Sensing with TRP channels. Nat Chem Biol. 2005;1(2):85–92.PubMedGoogle Scholar
84. 84.
    Cesare P, McNaughton P. A novel heat-activated current in nociceptive neurons and its sensitization by bradykinin. Proc Natl Acad Sci U S A. 1996;93(26):15435–9.PubMedGoogle Scholar
85. 85.
    Huang J, Zhang X, McNaughton PA. Inflammatory pain: the cellular basis of heat hyperalgesia. Curr Neuropharmacol. 2006;4(3):197–206.PubMedGoogle Scholar
86. 86.
    Fan HC, Zhang X, McNaughton PA. Activation of the TRPV4 ion channel is enhanced by phosphorylation. J Biol Chem. 2009;284(41):27884–91.PubMedGoogle Scholar
87. 87.
    Bandell M et al. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron. 2004;41(6):849–57.PubMedGoogle Scholar
88. 88.
    Helyes Z et al. Involvement of transient receptor potential vanilloid 1 receptors in protease-activated receptor-2-induced joint inflammation and nociception. Eur J Pain. 2010;14(4):351–8.PubMedGoogle Scholar
89. 89.
    Caterina MJ et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 2000;288(5464):306–13.PubMedGoogle Scholar
90. 90.
    Cho WG, Valtschanoff JG. Vanilloid receptor TRPV1-positive sensory afferents in the mouse ankle and knee joints. Brain Res. 2008;1219:59–65.PubMedGoogle Scholar
91. 91.
    Valdes AM et al. The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis. Ann Rheum Dis. 2011;70(9):1556–61.PubMedGoogle Scholar
92. 92.
    Brederson JD et al. TRPV1 antagonist, A-889425, inhibits mechanotransmission in a subclass of rat primary afferent neurons following peripheral inflammation. Synapse. 2012;66(3):187–95.PubMedGoogle Scholar
93. 93.
    Okun A et al. Afferent drive elicits ongoing pain in a model of advanced osteoarthritis. Pain. 2012;153(4):924–33.PubMedGoogle Scholar
94. 94.
    Katsura H et al. Antisense knock down of TRPA1, but not TRPM8, alleviates cold hyperalgesia after spinal nerve ligation in rats. Exp Neurol. 2006;200(1):112–23.PubMedGoogle Scholar
95. 95.
    McGaraughty S et al. TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats. Mol Pain. 2010;6:14.PubMedGoogle Scholar
96. 96.
    Schuelert N et al. Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis. Pain. 2011;152(5):975–81.PubMedGoogle Scholar
97. 97.
    Ahn K et al. Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain. J Pharmacol Exp Ther. 2011;338(1):114–24.PubMedGoogle Scholar
98. 98.
    Huggins JP et al. An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee. Pain. 2012;153(9):1837–46.PubMedGoogle Scholar
99. 99.
    Schuelert N et al. Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain. Osteoarthr Cartil. 2010;18(11):1536–43.PubMedGoogle Scholar
100. 100.
     Vriens J et al. TRPM3 is a nociceptor channel involved in the detection of noxious heat. Neuron. 2011;70(3):482–94.PubMedGoogle Scholar
101. 101.
     Todorovic S, Jevtovic-Todorovic V. Neuropathic pain: role for presynaptic T-type channels in nociceptive signaling. Pflugers Arch - Eur J Physiol. 2013;465(7):921–7.Google Scholar
102. 102.
     Rahman W et al. Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain. Mol Pain. 2009;5:45.PubMedGoogle Scholar
103. 103.
     Vonsy JL, Ghandehari J, Dickenson AH. Differential analgesic effects of morphine and gabapentin on behavioural measures of pain and disability in a model of osteoarthritis pain in rats. Eur J Pain. 2009;13(8):786–93.PubMedGoogle Scholar
104. 104.
     Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US 1980 vs. 2000. Pain. 2004;109(3):514–9.PubMedGoogle Scholar
105. 105.
     Gao R et al. Potent analgesic effects of a store-operated calcium channel inhibitor. Pain. 2013;154(10):2034–44.PubMedGoogle Scholar
106. 106.
     Knight MM et al. Articular chondrocytes express connexin 43 hemichannels and P2 receptors - a putative mechanoreceptor complex involving the primary cilium? J Anat. 2009;214(2):275–83.PubMedGoogle Scholar
107. 107.
     Varani K et al. Pharmacological characterization of P2X1 and P2X3 purinergic receptors in bovine chondrocytes. Osteoarthr Cartil. 2008;16(11):1421–9.PubMedGoogle Scholar
108. 108.
     Millward-Sadler SJ et al. ATP in the mechanotransduction pathway of normal human chondrocytes. Biorheology. 2004;41(3–4):567–75.PubMedGoogle Scholar
109. 109.
     Verkhratsky A, Steinhauser C. Ion channels in glial cells. Brain Res Brain Res Rev. 2000;32(2–3):380–412.PubMedGoogle Scholar
110. 110.
     Sagar DR et al. The contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic pain. Mol Pain. 2011;7:88.PubMedGoogle Scholar
111. 111.
     North RA, Jarvis MF. P2X receptors as drug targets. Mol Pharmacol. 2013;83(4):759–69.PubMedGoogle Scholar
112. 112.
     Bhattacharya A et al. Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567. Br J Pharmacol. 2013;170:624–40.Google Scholar
113. 113.
     Jenkins TW. Functional mammalian neuroanatomy, with emphasis on dog and cat, including an atlas of dog central nervous system, vol. xvii. Philadelphia: Lea & Febiger; 1972. 419 p.Google Scholar
114. 114.
     Craig Jr AD. Spinocervical tract cells in cat and dog, labeled by the retrograde transport of horseradish peroxidase. Neurosci Lett. 1976;3(4):173–7.PubMedGoogle Scholar
115. 115.
     Iannone F et al. Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes. Rheumatology. 2002;41(12):1413–8.PubMedGoogle Scholar